We show that the FoxO1/Rictor/pAktS473 axis is induced during ibrutinib treatment, and this helps CLL cells adapt and survive in peripheral blood, which associates with the extent of lymphocytosis following the treatment initiation. This evidence concerns the gene RICTOR and B-cell chronic lymphocytic leukemia.